OSSFF (Embla Medical hf) YoY EPS Growth: 36.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSSFF Embla Medical hf OSSFF
93 GF Score
Price $4.15
GF Value $4.93
View Full Analysis

What is Embla Medical hf YoY EPS Growth?

Embla Medical hf OSSFF 93 YoY EPS Growth is 36.00% as of Jun. 2026. GuruFocus rates OSSFF with a GF Score™ of 93/100 and a GF Value™ of $4.93.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Embla Medical hf's YoY EPS Growth for the quarter that ended in Jun. 2026 was 36.00%.

Embla Medical hf's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $0.07.

Embla Medical hf YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf YoY EPS Growth Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 933.33 -33.55 35.92 15.71 20.99

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.38 17.65 31.82 21.43 36.00
OSSFF
93GF Score
Embla Medical hf OSSFF
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Embla Medical hf's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(0.196-0.162)/ | 0.162 |
=20.99 %

Embla Medical hf's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(0.068-0.05)/ | 0.05 |
=36.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 36.00% mean?
Embla Medical hf (OSSFF) has a YoY EPS Growth of 36.00% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Embla Medical hf and its competitors.
Is Embla Medical hf's YoY EPS Growth too high?
Embla Medical hf's current YoY EPS Growth is 36.00%. Overall, Embla Medical hf has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's YoY EPS Growth compare to ABT and SYK?
Embla Medical hf's YoY EPS Growth of 36.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Devices & Instruments company?
A good YoY EPS Growth depends on the Medical Devices & Instruments industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Embla Medical hf and its competitors. Embla Medical hf's current YoY EPS Growth is 36.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current YoY EPS Growth of 36.00%. The stock's GF Value™ is $4.93, compared to a current price of $4.15 — trading 15.8% below its estimated fair value. The current YoY EPS Growth is 36.00%. Embla Medical hf's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current YoY EPS Growth is 36.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 15.8% below its estimated GF Value™ of $4.93.

Key valuation signals for OSSFF:

  • YoY EPS Growth: 36.00%
  • GF Value™: $4.93 vs. price of $4.15 (15.8% below fair value)
  • GF Score™: 93/100

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
93GF Score

Get the complete analysis for OSSFF

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$4.93
GF Value